Keymed Biosciences Inc.

HKEX:2162.HK

31.3 (HKD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019
Operating Activities:
Net Income -356.188-303.597-3,892.632-818.848-167.512
Depreciation & Amortization 69.16136.12321.01918.99212.299
Deferred Income Tax 0056.14500
Stock Based Compensation 40.07948.567116.82300
Change In Working Capital 22.425-5.672.828-0.187-6.945
Accounts Receivables -27.0913.98-3.9800
Inventory -11.859-28.102-9.547-3.54-3.235
Accounts Payables 0-3.983.9800
Other Working Capital 61.37522.43212.3753.353-3.71
Other Non Cash Items -79.097-177.3573,481.18680.68293.779
Operating Cash Flow -303.62-401.934-214.637-119.361-68.379
Investing Activities:
Investments In Property Plant And Equipment -327.194-279.549-172.858-19.896-62.302
Acquisitions Net 00-214.6210.038
Purchases Of Investments -905.237-5,651.169-2,753.082-676.965-257
Sales Maturities Of Investments 1,605.6975,076.15904.113572.083260.165
Other Investing Activites 94.937208.9826.9487.091.079
Investing Cash Flow 468.203-645.586-2,035.879-113.067-58.02
Financing Activities:
Debt Repayment 266.34375.432000.239
Common Stock Issued 002,887.64100
Common Stock Repurchased -32.901-51.135000
Dividends Paid 00000
Other Financing Activities -161.311-32.356750.7357.397504.827
Financing Cash Flow 72.131-8.0593,638.3767.397505.066
Other Information:
Effect Of Forex Changes On Cash 10.245139.03-66.65-8.1685.142
Net Change In Cash 246.959-916.5491,321.21-233.199383.809
Cash At End Of Period 851.029604.071,520.619199.409432.608